XML 41 R32.htm IDEA: XBRL DOCUMENT v3.23.1
STOCK-BASED COMPENSATION AND EQUITY (Tables)
3 Months Ended
Mar. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Total Stock-Based Compensation Expense The following table details total stock-based compensation expense for the three months ended March 31, 2023 and 2022, included in the condensed consolidated statements of income:
Three Months Ended March 31,
(In thousands)20232022
Costs of sales$181 $267 
Operating expenses1,066 1,450 
Pre-tax stock-based compensation expense1,247 1,717 
Less: income tax effect(274)(378)
Net stock-based compensation expense$973 $1,339 
Summary of Restricted Stock Activity
A summary of restricted stock activity under the Plan during the three months ended March 31, 2023 and 2022 is as follows:
Three Months Ended March 31, 2023Three Months Ended March 31, 2022
SharesWeighted-Average
Grant Date
Fair Value Per Share
SharesWeighted-Average
Grant Date
Fair Value Per Share
Unvested restricted stock outstanding at beginning of period281,161 $32.24 314,883 $29.79 
Granted185,487 29.23 144,064 34.44 
Vested(133,298)31.33 (174,943)29.75 
Unvested restricted stock outstanding at end of period333,350 $30.93 284,004 $32.17 
Summary of Performance Share Award Activity
A summary of performance share award activity under the Plan during the three months ended March 31, 2023 and 2022 is as follows, based on the target award amounts set forth in the performance share award agreements:
Three Months Ended March 31, 2023Three Months Ended March 31, 2022
SharesWeighted-Average
Grant Date
Fair Value Per Share
SharesWeighted-Average
Grant Date
Fair Value Per Share
Performance share awards outstanding at beginning of period252,375 $31.84 249,952 $29.59 
Granted123,406 31.21 101,799 37.98 
Forfeited or unearned(96,069)26.96 (25,948)31.75 
Earned and issued— — (27,317)31.75 
Performance share awards outstanding at end of period279,712 $33.24 298,486 $32.06